Intraoperative Bronchospasm: Clinical Presentation and Management
Clinical Presentation
Intraoperative bronchospasm presents with expiratory wheeze, prolonged exhalation, decreased pulmonary compliance, and falling oxygen saturation; in severe cases, complete silence on auscultation ("silent chest") indicates life-threatening airway obstruction requiring immediate intervention 1.
Key Presenting Signs (in order of frequency):
- Decreased pulmonary compliance (increased peak inspiratory pressures)
- Falling SpO₂ (progressive hypoxemia)
- Expiratory wheeze on auscultation
- Prolonged expiratory phase
- Silent chest (severe cases - indicates critical obstruction)
- Hypotension (may accompany severe bronchospasm)
- Hypercapnia with respiratory acidosis 1, 2
Timing and Context:
80% of non-allergic bronchospasm occurs during induction or maintenance of anesthesia 3. The most common triggers are:
- Airway irritation (35% of cases) - from intubation, suctioning, or volatile agents
- Endotracheal tube problems (23%) - malposition, kinking, or cuff issues
- Aspiration of gastric contents (14%)
- Anaphylaxis (present in 22% of bronchospasm cases) 1
Immediate Differential Diagnosis
Before treating bronchospasm, rapidly exclude mechanical causes that mimic it:
- Endotracheal tube obstruction - check position, patency, and cuff
- Equipment failure - verify ventilator function
- Pneumothorax - unilateral breath sounds
- Anaphylaxis - look for cardiovascular collapse (50.8%), cutaneous signs (71.9%), or angioedema (12.3%) 3
Critical distinction: If bronchospasm occurs with hypotension, cutaneous signs, or cardiovascular collapse, treat as anaphylaxis first with immediate epinephrine 3, 4.
Management Algorithm
Step 1: ABC Approach with Immediate Actions 3
Simultaneously execute:
- Increase FiO₂ to 100% immediately
- Deepen anesthesia with volatile agent (sevoflurane has bronchodilatory properties) 5, 2
- Remove potential triggers (stop IV colloids, latex exposure, antibiotics, chlorhexidine)
- Call for help and note the time
- Optimize ventilation: Reduce respiratory rate, prolong expiratory time, decrease tidal volume to avoid dynamic hyperinflation 5
Step 2: Pharmacologic Treatment (Multimodal Approach)
First-Line Therapy:
A. If bronchospasm ALONE (no anaphylaxis signs):
- Nebulized albuterol 2.5-5 mg in 3 mL saline, repeat as necessary 4
- Deepen anesthesia with sevoflurane (direct bronchodilator) 5, 2
- IV magnesium sulfate 2 g over 20 minutes 3, 5
- IV ketamine 0.5-1 mg/kg (bronchodilator and maintains anesthesia) 5
- IV lidocaine 1-1.5 mg/kg (reduces airway reactivity) 5
B. If anaphylaxis suspected (bronchospasm + hypotension/cutaneous signs):
- IV epinephrine 50 mcg (0.5 mL of 1:10,000) immediately - repeat every 1-2 minutes as needed 3
- Aggressive IV fluid resuscitation with 0.9% saline or lactated Ringer's at high rate 3
- If multiple epinephrine doses required: Start epinephrine infusion 1-10 mcg/min 4
Second-Line Therapy (if bronchospasm persists):
- IV salbutamol infusion 3
- IV aminophylline 3
- Additional magnesium sulfate 3
- IV dexmedetomidine (reduces airway reactivity) 5
Adjunctive Therapy:
- IV hydrocortisone 200 mg (adult dose) - won't help acutely but may prevent protracted bronchospasm 3, 4
- IV chlorphenamine 10 mg (adult dose) 3
- IV ranitidine 1 mg/kg (superior to H1 blocker alone if anaphylaxis) 4
Step 3: Ventilation Strategy
Avoid dynamic hyperinflation ("breath stacking"):
- Reduce respiratory rate to 6-8 breaths/min
- Prolong expiratory time (I:E ratio 1:3 or 1:4)
- Reduce tidal volume to 4-6 mL/kg
- Accept permissive hypercapnia (unless contraindicated)
- Avoid high PEEP initially (may worsen hyperinflation)
- Manual ventilation may provide better feel for compliance 5, 2
Step 4: If Refractory to All Measures
Consider VV-ECMO for life-threatening refractory bronchospasm with severe hypercapnic respiratory acidosis 6. This is a bridge therapy while bronchodilators take effect.
Special Considerations
β-Blocker Therapy Complicates Treatment:
- Bronchospasm may be refractory to epinephrine
- Epinephrine may paradoxically worsen hypotension (unopposed α-effects)
- Use glucagon 1-5 mg IV over 5 minutes, then infusion 5-15 mcg/min 4
- Aggressive fluid resuscitation is critical 4
Anaphylaxis Workup (if suspected):
Draw mast cell tryptase at three time points 3:
- Initial sample as soon as feasible (don't delay resuscitation)
- 1-2 hours after symptom onset
- 24 hours or convalescence (baseline level)
Post-Event Monitoring:
Continue close monitoring for 24-48 hours - bronchospasm can recur in the immediate postoperative period even after apparent resolution 7. Admit to high-dependency unit if severe episode occurred.
Common Pitfalls to Avoid
- Don't rely solely on inhaled β-agonists - multimodal therapy is essential 5
- Don't suction the endotracheal tube routinely before extubation - causes airway irritation and volume loss 8
- Don't use ZEEP during emergence - maintain positive pressure until extubation 8
- Don't miss anaphylaxis - if hypotension or cutaneous signs present, give epinephrine immediately 3
- Don't discharge too early - bronchospasm may recur within hours 7
- Don't forget to check tube position - 23% of bronchospasm cases are actually tube problems 1
- Don't hyperventilate - causes dynamic hyperinflation and cardiovascular collapse 5
Prevention Strategies
For patients with known asthma/reactive airways:
- Continue all bronchodilators through perioperative period 2
- Pre-treat with nebulized bronchodilators before induction 7
- Avoid airway instrumentation when possible (consider regional anesthesia) 9
- Deep extubation may reduce emergence bronchospasm in selected patients 10
- Optimize asthma control preoperatively - postpone elective surgery if poorly controlled 2
Intraoperative technique:
- Avoid histamine-releasing drugs (morphine, atracurium in high doses)
- Use volatile agents for maintenance (bronchodilatory)
- Minimize airway manipulation and suctioning
- Adequate depth before intubation/extubation 2